Blackstone sold a 9.5% stake in IT firm Mphasis for Rs 4,726 crore, reducing its holding to 30.64%. Meanwhile, Bain Capital ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

A North Wales pharmaceutical manufacturer backed by the Development Bank of Wales is accelerating its global expansion by launching two new products and unveiling plans to extend its global ...

Chief Revenue Officer of Meta Platforms Inc., John Hegeman, is stepping down as the... Public expenditure minister Jack Chambers warned Darragh O’Brien, the climate minister, ...

From pharmaceutical products that must remain within a strict temperature range to high-value technology moving across borders, high-stakes freight demands a higher standard of care. Werner Premium ...

Detailed price information for Rocket Lab Corporation (RKLB-Q) from The Globe and Mail including charting and trades.

Halozyme Therapeutics has acquired Elektrofi, a biopharmaceutical company with a proprietary ultra-high concentration ...

The Rs 500-crore initial share sale will open for public subscription on November 19, with price band of Rs 114-120 per share ...

The Phase 2 study is an open-label, fixed-sequence trial designed to evaluate the pharmacokinetic parameters and hemodynamic responses of NS002 compared to EpiPen in 50 healthy adults with a history ...

Acumen Pharmaceuticals to Present on Recruitment Strategies for Phase 2 ALTITUDE-AD Trial and Enhanced Brain Delivery Technology at 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference ...